Related Experiment Video
Updated: Feb 3, 2026

Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes
Yajun Chen1, Feng Yang2, Erhu Fang2
1Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, 430022, Wuhan, Hubei Province, China.
Abstract:
Argonaute 2 (AGO2), the core component of microRNA (miRNA)-induced silencing complex, plays a compelling role in tumorigenesis and aggressiveness. However, the mechanisms regulating the functions of AGO2 in cancer still remain elusive. Herein, we indentify one intronic circular RNA (circRNA) generated from AGO2 gene (circAGO2) as a novel regulator of AGO2-miRNA complexes and cancer progression. CircAGO2 is up-regulated in gastric cancer, colon cancer, prostate cancer, and neuroblastoma, and is associated with poor prognosis of patients. CircAGO2 promotes the growth, invasion, and metastasis of cancer cells in vitro and in vivo. Mechanistic studies reveal that circAGO2 physically interacts with human antigen R (HuR) protein to facilitate its activation and enrichment on the 3'-untranslated region of target genes, resulting in reduction of AGO2 binding and repression of AGO2/miRNA-mediated gene silencing associated with cancer progression. Pre-clinically, administration of lentivirus-mediated short hairpin RNA targeting circAGO2 inhibits the expression of downstream target genes, and suppresses the tumorigenesis and aggressiveness of xenografts in nude mice. In addition, blocking the interaction between circAGO2 and HuR by cell-penetrating inhibitory peptide represses the tumorigenesis and aggressiveness of cancer cells. Taken together, these results indicate that oncogenic circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes.
Insights
A novel circular RNA (circRNA) called circAGO2 promotes cancer by interfering with Argonaute 2 (AGO2) and microRNA (miRNA) silencing. Targeting circAGO2 or its interaction with HuR protein inhibits tumor growth and spread.
Area of Science:
- Molecular Biology
- Oncology
- RNA Biology
Background:
- Argonaute 2 (AGO2) is crucial for microRNA (miRNA)-mediated gene silencing and implicated in cancer.
- The regulatory mechanisms governing AGO2 function in cancer remain incompletely understood.
- Circular RNAs (circRNAs) are emerging as significant players in various biological processes, including cancer.
Purpose of the Study:
- To identify and characterize novel regulators of AGO2 function in cancer.
- To investigate the role of circRNAs in modulating AGO2-miRNA complexes.
- To explore circAGO2 as a potential therapeutic target for cancer treatment.
Main Methods:
- Identification and characterization of circAGO2 derived from the AGO2 gene.
- Expression analysis of circAGO2 in various cancer types (gastric, colon, prostate, neuroblastoma).
- In vitro and in vivo assays to assess the functional role of circAGO2 in cancer cell growth, invasion, and metastasis.
- Mechanistic studies involving RNA-protein interaction assays (e.g., RIP-qPCR) to investigate the interaction between circAGO2 and HuR.
- Therapeutic interventions using shRNA targeting circAGO2 and cell-penetrating peptides to block circAGO2-HuR interaction in preclinical models.
Main Results:
- CircAGO2 is significantly upregulated in multiple cancers and correlates with poor patient prognosis.
- CircAGO2 promotes cancer cell proliferation, invasion, and metastasis both in vitro and in vivo.
- CircAGO2 interacts with HuR protein, enhancing its activity and leading to reduced AGO2 binding and impaired miRNA-mediated gene silencing.
- Targeting circAGO2 with shRNA or blocking its interaction with HuR using peptides effectively suppresses tumor growth and aggressiveness in preclinical models.
Conclusions:
- Oncogenic circAGO2 acts as a novel regulator of AGO2-miRNA complexes in cancer progression.
- CircAGO2 drives tumorigenesis and metastasis by facilitating HuR-mediated repression of AGO2/miRNA silencing.
- CircAGO2 and its interaction with HuR represent promising therapeutic targets for inhibiting cancer growth and spread.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Facilitated Transport
Facilitated Transport
Repressed Memory
Social Facilitation
Facilitated Diffusion
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...

